Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06892938 · ClinicalTrials.gov registry record

Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring

A clinical trial of Bradycardia and Arrhythmias, Cardiac, sponsored by Everbeat.

Active
Registry status
232
Enrollment target
3
Study locations

NCT06892938 is a study of Bradycardia and Arrhythmias, Cardiac that is active but no longer recruiting, run by Everbeat. The registered enrollment target is 232 participants, below the 4,405-participant average among 29 other Bradycardia trials with a reported enrollment target (95% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06892938, a study of Bradycardia and Arrhythmias, Cardiac, is active but no longer recruiting, sponsored by Everbeat.

ACTIVE NOT RECRUITING
Registry status
232 participants
Enrollment target
3
Study locations

Study Summary

Everbeat is a finger-worn ring that has a built-in electrocardiogram (ECG). In this study the investigators ensure that the ECG as read by the everbeat correctly classifies heart rhythms and detects atrial fibrillation. Investigators will also correlate the everbeat ECG waveform with a clinical-grade FDA approved electrocardiogram to ensure it may be reliably interpreted by clinicians or other algorithms.

Interventions

  • DIAGNOSTIC_TEST Atrial Fibrillation Identification

Study Locations (3)

California

  • XIMED - La Jolla

Louisiana

  • Our Lady of Lake Hospital - Baton Rouge

Pennsylvania

  • Allegheny General Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 232 participants
Start Date 2024-09-17
Est. Completion 2025-04-01

Sponsor

Everbeat

1 total trials

What the Registry Record Tells You About NCT06892938

The ClinicalTrials.gov registry entry for NCT06892938 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,405-participant average among 29 other Bradycardia trials with a reported enrollment target (95% lower). The listed sponsor is Everbeat, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which Atrial Fibrillation Identification is the first listed.

NCT06892938 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Louisiana, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06892938 about?

NCT06892938 is a clinical study titled "Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring". Everbeat is a finger-worn ring that has a built-in electrocardiogram (ECG). In this study the investigators ensure that the ECG as read by the everbeat correctly classifies heart rhythms and detects atrial fibrillation. Investigators will also correlate the everbeat ECG waveform with a clinical-grad...

What is the current status of trial NCT06892938?

This trial is currently active not recruiting. The enrollment target is 232 participants. The study started on 2024-09-17. Estimated completion is 2025-04-01.

What conditions does trial NCT06892938 study?

This clinical trial studies the following conditions: Bradycardia, Arrhythmias, Cardiac, Atrial Fibrillation (AF), Tachycardia, Palpitations.

What interventions are being tested in trial NCT06892938?

The interventions under investigation include: Atrial Fibrillation Identification (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06892938?

This trial is sponsored by Everbeat, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06892938 being conducted?

This trial has 3 study locations across California, Louisiana, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bradycardia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.